Protective effects of an aged garlic extract on doxorubicin‐induced cardiotoxicity in the mouse
- 1 January 1994
- journal article
- other
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 22 (2) , 163-173
- https://doi.org/10.1080/01635589409514341
Abstract
Protective effects of an aged garlic extract on the cardiotoxicity of doxorubicin (DOX) was evaluated using the mouse. DOX (1.5 mg/kg body wt ip) was administered three times per week for 40 days. An aged garlic extract, WG‐1 (a preserved stock solution; Wakunaga Pharmaceutical) was administered intraperitoneally six times weekly. DOX caused changes in the electrocardiogram. In the control mice, the width of the QRS complex was 20 ± 2.8 milliseconds, the R‐R interval was 130 ± 2.8 milliseconds, and the P‐Q interval was 30 ± 1.4 milliseconds. In mice treated with DOX for 40 days, the width of the QRS complex was 50 ± 10 milliseconds (p < 0.05), the R‐R interval was 240 ± 30 milliseconds (p < 0.05), and the P‐Q interval was 45 ± 1.0 milliseconds (p < 0.01). These values were significantly smaller in mice treated with WG‐1 + DOX than in mice treated with DOX. The width of the QRS complex was 29.3 ±5.8 milliseconds (p < 0.05), the R‐R interval was 145.8 ± 17.9 milliseconds (p < 0.01), and the P‐Q interval was 37.8 ± 3.5 milliseconds (p < 0.05). The lipid peroxidation in the heart homogenates prepared from DOX‐treated mice, as measured by thiobarbituric acid‐reactive substance (TBARS, nmol malondialdehyde/100 mg protein) was 332.5 ± 67.0, which was significantly larger than that in the control mice (186.6 ± 42.2) (p < 0.05). WG‐1 decreased the level of TBARS in DOX‐treated mice significantly. In the mice treated with WG‐1 + DOX, TBARS was 221.3 ± 31.6, which was significantly smaller than that of DOX‐treated mice (p < 0.05). Histological study demonstrated that the heart treated with DOX had vacuolization in muscle cells, disrupted myofibrils, and swollen mitochondria. Mice that received WG‐1 + DOX had no significant pathological lesions in the heart.Keywords
This publication has 14 references indexed in Scilit:
- Doxorubicin‐lnduced Cardiotoxicosis Clinical Features in 32 DogsJournal of Veterinary Internal Medicine, 1992
- Cardiotoxicity and cytotoxicity of the anthracycline analog 4′-deoxy-4′-iodo-doxorubicinToxicology, 1991
- Early cardiac toxicity of 4′-iodo-4′-deoxydoxorubicinEuropean Journal of Cancer and Clinical Oncology, 1991
- Cardiac Arrhythmias in Patients with Small Cell Lung Cancer and Cardiac Disease Before, During and After Doxorubicin Administration an Evaluation of Acute Carditoxicity by Continuous 24-Hour Holter MonitoringActa Oncologica, 1991
- A phase II study of pirarubicin in malignant pleural mesotheliomaCancer, 1990
- Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected casesInvestigational New Drugs, 1990
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979
- Adriamycin and the HeartNew England Journal of Medicine, 1979
- Adriamycin stimulated superoxide formation in submitochondrial particlesChemico-Biological Interactions, 1977
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977